While some evidence supports the use of recombinant human prolactin, it is not currently approved for medical use.[2][7] Treatment generally involves formula feeding the baby.[5] Prolactin deficiency alone is rare.[2] It occurs in about 17% of cases of hypopituitarism or about 8 per 100,000 people in Spain as of 1999.[2]